Close mobile menu×
Close mobile menu

Elizabeth C. Verna, MD

Board Certifications: 
Transplant Hepatology, Internal Medicine, Gastroenterology
Expertise in: 
Cancer Care
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-0914

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Transplant Hepatology
  • Internal Medicine
  • Gastroenterology

Clinical Expertise

  • Cancer Care
  • End Stage Liver Disease
  • Non-Alcoholic Fatty Liver Disease
  • Viral Hepatitis
  • Hepatitis C
  • Liver Cancer
  • Liver Disease

Education & Training

  • Columbia University College of Physicians and Surgeons
  • Residency: NewYork-Presbyterian/Columbia
  • Fellowship: NewYork-Presbyterian/Columbia

About Elizabeth Verna

Dr. Elizabeth C. Verna manages patients with a variety of liver diseases. Her clinical interests focus on viral hepatitis and liver transplantation as well as the new emerging therapies for hepatitis C, liver cancer, alcoholic and non-alcoholic fatty liver disease and metabolic liver diseases. She also has expertise in the management of end stage liver disease and its complications.

Academic Titles

  • Assistant Professor of Medicine at CUMC

Committee/Societies/Council Memberships

  • American Society of Transplantation
  • American Association for the Study of Liver Diseases. 2011 Training and Clinical Policy Committee Member
  • American Gastroenterological Association

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Weill Cornell

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Access (Exchange)
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
622 West 168th Street
Suite PH 14E, Room 104
New York, New York 10032
Phone: (212) 305-0914
Primary

Research

Active research program with grant support for the study of hepatitis C in liver transplant recipients and will be actively involved in clinical trials forthe treatment of hepatitis C in both the transplant and non-transplant settings.

Grants

  • 2011-2013 National Institutes of Health K12 Career Development Award, Columbia University College of Physicians and Surgeons
  • 2011-2013 American Association for the Study of Liver Diseases Sheila Sherlock Clinical and Translational Research Award, Columbia University College of Physicians and Surgeons
  • 2010-2011 American College of Gastroenterology Clinical Research Award
  • Columbia University College of Physicians and Surgeons
  • 2010-2011 American Association for the Study of Liver Diseases Advanced/Transplant Hepatology
  • Fellowship Award, Columbia University College of Physicians and Surgeons
  • 2010-2011 Glenda Garvey Teaching Academy Award (Co-Investigator) for "Women in 3D" and alcohol awareness initiative targeting young women, Columbia University College of Physicians and Surgeons
  • 2009-2010 National Institutes of Health T32 Training Grant
  • Columbia University College of Physicians and Surgeons
  • 2008-2010 Patient Oriented Research Scholarship for a Masters in Biostatistics
  • Columbia University Mailman School of Public Health

A 5-YEAR LONGITUDINAL OBSERVATIONAL STUDY OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (P&S Industry Clinical Trial)

Apr 5 2017 - Apr 5 2022

A MULTICENTER, OPEN-LABEL STUDY OF HARVONI? (SOFOSBUVIR LEDIPASVIR FIXED DOSE COMBINATION) IN SUBJECTS INFECTED WITH CHRONIC HEPATITIS C AND ADVANCED HEART FAILURE OR LUNG DISEASE (P&S Industry Clinical Trial)

Mar 6 2017 - Mar 6 2022

THE PRIORITIZE STUDY: A PRAGMATIC, RANDOMIZED STUDY OF ORAL REGIMENS FOR HEPATITIS C: TRANSFORMING DECISION-MAKING FOR PATIENTS, PROVIDERS, AND STAKEHOLDERS. (Private)

Mar 1 2016 - Feb 28 2021

BACTERIAL TRANSLOCATION AND THE INTESTINAL MICROBIOME IN RECURRENT DISEASE FOLLOWING LIVER TRANSPLANTATION (Federal Gov)

Sep 1 2015 - Aug 31 2019

A MULTICENTER, DOUBLE-BLIND, SPONSOR-OPEN TRIAL OF IDN-6556 IN SUBJECTS WHO HAD HEPATITIS C VIRUS (HCV) REINFECTION AND LIVER FIBROSIS FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION FOR CHRONIC HCV INFECTION (P&S Industry Clinical Trial)

Jul 24 2014 - Jul 24 2019

A PHASE II/III CLINICAL TRIAL TO STUDY THE EFFICACY AND SAFETY OF THE COMBINATION REGIMEN OF MK-5172 AND MK-8742 IN SUBJECTS WITH CHRONIC HEPATITIS C VIRUS INFECTION WITH ADVANCED CIRRHOSIS AND CHILD-PUGH (P&S Industry Clinical Trial)

Jun 19 2014 - Jun 19 2019

A PHASE II/III RANDOMIZED CLINICAL TRIAL TO STUDY THE EFFICACY AND SAFETY OF THE COMBINATION REGIMEN OF MK-5172 AND MK-8742 IN SUBJECTS WITH CHRONIC HEPATITIS C VIRUS INFECTION AND CHRONIC KIDNEY DISEASE (P&S Industry Clinical Trial)

Apr 17 2014 - Apr 17 2019

PROSPECTIVE, SINGLE-CENTER, OPEN LABEL, PILOT STUDY OF SAFETY AND EFFICACY OF TRIPLE ANTI-VIRAL THERAPY WITH PEGYLATED INTERFERON, RIBAVIRIN, AND BOCEPREVIR IN PATIENTS WITH GENOTYPE 1 CHRONIC HCV WITH END STAGE RENAL DISEASE (P&S Industry Clinical Trial)

Dec 23 2013 - Dec 23 2018

A MULTICENTER, RANDOMIZED, PROSPECTIVE, OPEN-LABEL PHASE III STUDY TO EVALUATE THE EFFICACY, SAFETY AND PHARMACOKINETICS OF HEPATITIS C IMMUNE GLOBULIN INTRAVENOUS (P&S Industry Clinical Trial)

Aug 15 2013 - Aug 15 2018

INTEGRATED APPROACHES FOR IDENTIFYING MOLECULAR TARGETS IN ALCOHOLIC HEPATITIS (Federal Gov)

Jun 1 2013 - May 31 2017

INTEGRATED APPROACHES FOR IDENTIFYING MOLECULAR TARGETS IN ALCOHOLIC HEPATITIS (Federal Gov)

Jun 1 2013 - Apr 30 2017

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (KL2) (Federal Gov)

Sep 30 2006 - Jun 30 2016

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (KL2) (Federal Gov)

Sep 30 2006 - Jun 30 2016

INTEGRATED APPROACHES FOR IDENTIFYING MOLECULAR TARGETS IN ALCOHOLIC HEPATITIS (Federal Gov)

Jun 1 2013 - May 31 2016

FRAILTY AND FUNCTIONAL STATUS IN OLDER LIVER TRANSPLANT PATIENTS (Federal Gov)

Sep 1 2015 - Apr 30 2016

Selected Publications

Peer Reviewed Publications

  • Verna EC, Ferrand E, Pichardo EM, Balducci A, Emond JC, Guarrera J, Brown RS. “Basiliximab
  • Induction and Delayed Calcineurin Inhibitor Initiation in Liver Transplant Recipients with Renal
  • Failure.” Transplantation, In press.
  • Lai JC, Verna EC, Brown RS, O-Leary J, Trotter J, Forman LM, Dunman J, Foster RG, Stravitz RT,
  • Terrault NA. “Hepatitis C Virus Infected Females are at a Higher Risk of Advanced Firbosis and
  • Graft Loss after Liver Transplantation: From the CRUSH-C Consortium.” Hepatology, In press.
  • Chang MS, Shah JP, Amin S, Gonzalez, S, Prowda JC, Cheng JM, Verna EC, Rockey DC, Frucht H.
  • “Physician Knowledge and Appropriate Utilization of Computer Tomographic Colonography in
  • Colorectal Cancer Screening.” Abdomin Imaging, In press.
  • Rossi ED, Larghi A, Verna EC, Martini M, Galasso D, Carnuccio A, Larocca LM, Costamagna G, Fadda G.”
  • Endoscopic ultrasound-guided fine-needle aspiration with liquid-based cytologic preparation in the
  • diagnosis of primary pancreatic lymphoma.” Pancreas, 2010 Nov;39(8):1299-302.
  • Verna EC, Stevens PD, Hwang C, Stavropoulos S, Sy C, Fine R, Chabot JA, Frucht H. “Pancreatic
  • Cancer Screening in a Prospective Cohort of High Risk Patients: A Comprehensive Strategy of
  • Genetics and Imaging.” Clinical Cancer Res 2010, 15;16(20):5028-37.
  • Verna EC, De Martin E, Gaglio PJ, Burra P, Emond JC, Brown RS. “The Impact of Hepatitis C and
  • Biliary Complications on Patient and Graft Survival Following Liver Transplantation.” Am J
  • Transplant May 2009;9(6):1398-405.Elizabeth Verna - Curriculum Vitae 3
  • Verna EC, Hunt KH, Rudow DL, Hafliger A, Dove LM, Kinkhabwala M, Emond JC, Brown RS.
  • “Predictors of Candidate Maturation Among Potential Living Donors.” Am J Transplant. 2005
  • Oct; 5: 2549-54.
  • Stavropoulos SN, Larghi A, Verna EC, Battezzati PM, Stevens PD. “Intraductal Ultrasound for the
  • Evaluation of Patients with Biliary Strictures and No Abdominal Mass on Computed
  • Tomography.” Endoscopy 2005 Aug;37(8):715-21.
  • Stavropoulos SN, Larghi A, Verna EC, Stevens PD. “Therapeutic ERCP Without Fluoroscopy in
  • Critically Ill Patients Using Wire-Guided Intraductal Ultrasound.” Endoscopy 2005
  • Apr;37(4):389-92.
  • Larghi A, Verna EC, Stavropoulos SN, Rotterdam H, Lightdale CJ, Stevens PD. “EUS-Guided
  • Trucut Needle Biopsies in Patients With Solid Pancreatic Masses: a Prospective Study.”
  • Gastrointest Endosc 2004 Feb;59(2):185-90.

Chapters, Reviews, and Editorials

  • Verna EC, Brown RS “The Use of HCV Positive Organs in Patients With and Without HCV”, Edited by
  • Shiffman M, “Chronic Heptitis C Virus: Lessons from the Past, Promises for the Future,” Springer
  • Publishing, In Press.
  • Verna EC “Hepatitis C Virus”, Edited by Brown RS, “Common Liver Diseases and Transplantation: An
  • Algorithmic Approach to Work-up and Management”, Slack Inc., In Press.
  • Oliver J, Verna EC. “Afferent Mechanisms of Sodium Retention in Cirrhosis and Hepatorenal
  • Syndrome.” Kidney International, 2010;77(8):669-80.
  • Verna EC, Brown RS. “Hepatitis C and Liver Transplantation.” www.uptodate.com.
  • Verna EC, Lucak S. “Use of Probiotics in Gastrointestinal Disorders: What to Recommend.”
  • Therapeutic Advances in Gastroenterology, 2010; 3: 307-319.
  • Verna EC, Brown RS. “HCV and HIV Coinfection Emerging as an Important Clinical Problem.”
  • Gastroenterology and Hepatology News, October, 2009.
  • Verna EC, Larghi A. “Endoscopic Submucosal Dissection: Learning from the Japanese Experience.”
  • Dig Liver Dis 2009;41(3):210-1.
  • Larghi A, Verna EC, Lecca PG, Del Chiaro M, Costamagna G. “Screening for Pancreatic Cancer in
  • High Risk Individuals: A Call for Endoscopic Ultrasound.” Clinical Cancer Res 2009;15:1907-
  • 1914.
  • Verna EC. “Indications for Use of TIPS in Treating Portal Hypertension.” American Medical
  • Association Virtual Mentor. December 2008, Volume 10, Number 12:805-809.
  • http://virtualmentor.ama-assn.org/2008/12/cprl1-0812.html. Accessed Dec. 1, 2008.
  • Verna EC, Burke PD. “Role of Fatty Acids in the Pathogenesis of Obesity and Fatty Liver: Impact
  • of Bariatric Surgery” Seminars Liver Dis. 2008;28:407-26.Elizabeth Verna - Curriculum Vitae 4
  • Verna EC, Dhar V. “Endoscopic Ultrasound-guided Fine Needle Injection for Cancer Therapy: The
  • Evolving Role of Therapeutic Endoscopic Ultrasound.” Therapeutic Advances in
  • Gastroenterology 2008;1:103-109.
  • Verna EC, Brown RS. “Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should
  • They Be Re-transplanted.” Clin Liver Dis, 2008;12:637-659.
  • Verna EC, Brown RS. “Hepatitis C and Liver Transplantation.” Clin Liver Dis 2006;10:919-940.
  • Stevens PD, Verna EC, Lightdale CJ. “Endoscopic Ultrasound of the Biliary Tract.”, Edited by
  • Blumgart L and Fong Y, “Surgery of the Liver and Biliary Tract”, Elsevier Inc., 2006.
  • Verna EC, Larghi A. “How Effective is Endoscopic Ultrasound-Guided Biopsy?” Nat Clin Pract
  • Gastroenterol Hepatol 2006;3(4):200-1.
  • Sharaf RN, Verna EC, Green PD. “Commentary: The International Face of Celiac Disease.”
  • Digestive Liver Dis 2004;36(11):712-3.
  • Frucht H, Stevens PD, Fogelman DR, Verna EC, Chen J, Chabot JA, Fine RL. “Advances in the
  • Genetic Screening, Work-up and Treatment of Pancreatic Cancer.” Curr Treat Options
  • Gastroenterol 2004;7(5):343-354.